ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
아나필락시스 시장 규모는 최근 몇 년 동안 강력하게 성장하고 있습니다. 2024년 32억 4,000만 달러에서 2025년에는 35억 달러에 달하고, CAGR 8.1%를 나타낼 전망입니다. 성과기간 성장은 식품 알레르기 유병률 증가, 아나필락시스 인지도 향상, 건강 인프라 성장, 더 나은 진단 및 관리, 에피네프린 자동 주사기의 가용성 증가로 인한 것입니다.
아나필락시스 시장 규모는 앞으로 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.1%를 나타내 47억 8,000만 달러로 성장할 전망입니다. 예측기간 성장의 배경으로는 도시화와 라이프스타일 변화, 아나필락시스 증례 증가, 신흥 시장의 가처분소득 증가, 알레르기 연구에 대한 정부의 자금 지원, 긴급 치료를 위한 전달 시스템 혁신 등이 있습니다. 예측 기간의 주요 동향으로는 주사용 자동 주사기 수요 증가, 아나필락시스 관리에 있어서의 디지털 헬스 솔루션의 통합, 제품의 가격경감에 대한 주목의 높아짐, 예방치료와 백신 증가, 알레르기 치료에 있어서의 생물제제의 사용 증가 등을 들 수 있습니다.
아나필락시스는 호흡곤란, 부종, 혈압저하 등의 증상을 일으키고 생명을 위협할 수도 있는 빠르고 심각한 알레르기 반응입니다. 응급 의료 치료가 필요하며 에피네프린이 효과를 회복시키는 주요 치료법입니다. 에피네프린 투여 후 환자의 상태를 안정시키고 합병증을 피하기 위해 의료기관에서 경과를 관찰합니다.
아나필락시스의 관리에 사용되는 주요 약물 클래스별로는 에피네프린, 스테로이드, 항히스타민제, 베타 길항제 등이 있습니다. 에피네프린은 혈관을 수축시키고기도 근육을 이완시키고 심박수를 증가시켜 심각한 알레르기 반응을 회복시키는 데 매우 중요합니다. 이러한 약물은 비경구, 경구 등 다양한 경로로 투여되며, 식품 알레르기, 꽃가루, 진드기 등에 의한 것들을 포함한 다양한 유형의 알레르기 반응의 치료에 사용됩니다.
2025년 봄 미국 관세의 급상승과 이에 따른 무역 마찰은 의료 분야, 특히 필수적인 의료기기, 진단 장비 및 의약품 공급에 큰 영향을 미쳤습니다. 병원과 건강 관리 제공업체는 수입되는 수술 기구, 영상 진단 시스템, 주사기 및 카테터와 같은 소모품의 비용 상승에 시달리고 있으며, 그 대부분은 국내 대체품이 제한되어 있습니다. 이러한 비용 상승이 의료 예산을 압박하기 때문에 일부 의료기관은 장비 업그레이드를 늦추거나 비용 증가를 환자에게 전가하고 있습니다. 게다가 원료와 부품에 대한 관세는 중요한 의약품과 의료기기의 제조에 지장을 주고 공급망의 지연으로 이어지고 있습니다. 이에 비해 업계는 다양한 조달 전략을 채택하고 가능한 한 현지 생산을 확대하고 중요한 의료 제품의 관세 면제를 수행하고 있습니다.
이 설문조사 보고서는 아나필락시스 산업 세계 시장 규모, 지역 점유율, 아나필락시스 시장 점유율을 가진 경쟁업체, 상세한 아나필락시스 시장 부문, 시장 동향 및 비즈니스 기회, 아나필락시스 업계에서 성공하는 데 필요한 데이터 등 아나필락시스 시장 통계를 제공하는 The Business Research Company의 신간 보고서 시리즈 중 하나입니다. 이 아나필락시스 시장 조사 보고서는 업계의 현재 및 미래 시나리오를 자세히 분석하고 필요한 모든 것을 완벽한 관점에서 제공합니다.
향후 5년간의 성장률 8.1%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과로 영국과 스위스에서 수입되는 에피네프린 자동주사기와 정주용 항히스타민제의 비용이 상승하고 신속한 대응능력이 손상될 수 있으며, 긴급구명실(ER)의 약제비도 상승하기 때문에 미국의 응급의료가 혼란될 가능성이 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
식품 알레르기의 유병률 증가는 앞으로 수년간 아나필락시스 시장 성장을 가속할 것으로 예측됩니다. 음식 알레르기는 특정 음식에 의해 유발되는 면역계 반응이며, 생명을 위협하는 아나필락시스를 포함한 경증에서 심한 증상을 유발합니다. 음식 알레르기의 유병률 증가는 식습관 변화, 환경 영향, 인식 및 진단 향상과 같은 요인으로 인해 발생합니다. 아나필락시스 치료는 음식 알레르기 환자에게 구명적 개입을 제공하고 심각한 알레르기 반응을 신속하게 회복시키고 부종, 호흡 곤란, 혈압 저하 등의 증상을 완화하고 즉각적으로 안정화시키고 치명적일 수 있는 결과를 방지하는 중요한 역할을 합니다. 또한 미래의 알레르기 발생 시 적시에 행동할 수 있는 도구를 환자에게 제공합니다. 예를 들어 2024년 9월 세계보건기구(WHO)는 세계 약 2억 2천만 명이 음식 알레르기의 영향을 받고 있다고 보고했습니다. 하나의 제품 유형에 여러 알레르겐이 포함될 수 있으며 여러 유형의 식품에 알레르기가있을 수 있습니다. 또한 식품기준청(FSA)은 2024년 5월 보고서를 발표했으며 영국 성인의 30% 이상이 식품 관련 부작용을 경험했으며 임상 평가에서는 영국 성인의 약 6%(약 240만 명)에 음식 알레르기가 확인된 것으로 나타났습니다. 따라서 식품 알레르기의 유병률 증가는 아나필락시스 시장 성장을 가속합니다.
아나필락시스 시장 기업들은 응급 상황에서 신속하고 효율적인 약물 전달을 가능하게 하는 에피네프린 점비약의 개발과 같은 치료의 발전에 주력하고 있습니다. 에피네프린 점비 스프레이는 아나필락시스를 비롯한 심각한 알레르기 반응의 치료제로서 에피네프린(아드레날린)을 비강에서 투여하는 의료기기입니다. 예를 들어, 2024년 8월 미국의 생명공학 기업인 ARS Pharmaceuticals는 Neffy(에피네프린 점비 스프레이)가 미국 식품의약국(FDA)으로부터 승인을 받았으며 아나필락시스를 포함한 i형 알레르기 반응에 대한 최초의 유일한 바늘을 사용하지 않는 치료제가 되었다고 발표했습니다. 이 혁신적인 비강 스프레이는 전통적인 에피네프린 자동 주사기를 대체하는 비침습적인 대안을 제공하여 응급 치료의 더 친숙한 옵션이 될 수 있습니다. Neffy는 주사 바늘을 필요로 하지 않고 심각한 알레르기 반응 시 신속하고 구명적인 에피네프린을 제공함으로써 환자의 컴플라이언스를 향상시키는 것을 목표로 하고 있습니다.
2023년 10월, 스위스에 본사를 둔 영양과학회사 네슬레 헬스사이언스 SA는 심각한 알레르기가 있는 사람들을 돕기 위해 아나필락시스 영국과 제휴했습니다. 이 제휴는 아나필락시스의 심각한 결과에 대한 인식을 높이고 교육과 자원을 제공함으로써 알레르기를 안전하게 관리할 수 있도록 하기 위한 것입니다. 아나필락시스 UK는 심각한 알레르기에 초점을 맞춘 영국을 기반으로 한 자선 단체입니다.
아나필락시스 시장은 주사기와 바이알, 정맥 주사용 에피네프린, 진단 키트, 모니터링 장비로 구성되어 있습니다. 이 시장의 가치는 "Factory Gate"가치, 즉 상품의 제조자 또는 제조자가 다른 기업(강하의 제조자, 도매업체, 유통업체, 소매업체 포함) 또는 직접 최종 고객에게 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품 제작자에 의해 판매되는 관련 서비스도 포함됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 아나필락시스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 아나필락시스 시장 : 성장률 분석
세계의 아나필락시스 시장 실적 : 규모와 성장(2019-2024년)
세계의 아나필락시스 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 아나필락시스 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 아나필락시스 시장 : 약제 클래스별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
에피네프린
스테로이드
항히스타민제
베타 차단제
기타 약제 클래스
세계의 아나필락시스 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
비경구
경구
기타 투여 경로
세계의 아나필락시스 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
식품 알레르기
꽃가루 알레르기
집먼지진드기 알레르기
기타 용도
세계의 아나필락시스 시장 : 에피네프린 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
자동 주사기
사전 충전 주사기
바이알
세계의 아나필락시스 시장 : 스테로이드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
코르티코스테로이드
글루코코르티코이드
미네랄코르티코이드
세계의 아나필락시스 시장 : 항히스타민제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
H1 수용체 길항제
H2 수용체 길항제
세계의 아나필락시스 시장 : 베타 차단제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
선택적 베타 차단제
비선택적 베타 차단제
세계의 아나필락시스 시장 : 기타 약제 클래스 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
류코트리엔 수용체 길항제
비만세포 안정제
제7장 지역별/국가별 분석
세계의 아나필락시스 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 아나필락시스 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
아나필락시스 시장 : 경쟁 구도
아나필락시스 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sanofi SA
AstraZeneca plc
Abbott Laboratories
GlaxoSmithKline Plc
F. Hoffman-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Perrigo Company plc
Dr Reddy's Laboratories Ltd.
Cipla Ltd.
Amneal Pharmaceuticals Inc.
Mylan NV
ALK-Abello
Stallergenes Greer
Allergy Therapeutics
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
아나필락시스 시장(2029년) : 새로운 기회를 제공하는 국가
아나필락시스 시장(2029년) : 새로운 기회를 제공하는 부문
아나필락시스 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Anaphylaxis is a rapid, severe allergic reaction that can be life-threatening, leading to symptoms such as difficulty breathing, swelling, and a drop in blood pressure. It requires urgent medical attention, with epinephrine being the primary treatment to reverse the effects. After the administration of epinephrine, patients are monitored in a healthcare setting to stabilize their condition and avoid complications.
The main drug classes used in the management of anaphylaxis include epinephrine, steroids, antihistamines, beta-antagonists, and others. Epinephrine is crucial in reversing severe allergic reactions by constricting blood vessels, relaxing airway muscles, and increasing heart rate. These medications are administered through different routes such as parenteral, oral, and others, and are used to treat various types of allergic reactions, including those caused by food allergies, pollen, dust mites, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The anaphylaxis market research report is one of a series of new reports from The Business Research Company that provides anaphylaxis market statistics, including anaphylaxis industry global market size, regional shares, competitors with an anaphylaxis market share, detailed anaphylaxis market segments, market trends and opportunities, and any further data you may need to thrive in the anaphylaxis industry. This anaphylaxis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anaphylaxis market size has grown strongly in recent years. It will grow from $3.24 billion in 2024 to $3.5 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the rising prevalence of food allergies, increased awareness of anaphylaxis, growing healthcare infrastructure, better diagnosis and management, and increasing availability of epinephrine auto-injectors.
The anaphylaxis market size is expected to see strong growth in the next few years. It will grow to $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing urbanization and lifestyle changes, a growing incidence of anaphylaxis cases, rising disposable incomes in emerging markets, government funding for allergy research, and innovations in delivery systems for emergency treatment. Major trends in the forecast period include growing demand for injectable auto-injectors, integration of digital health solutions in anaphylaxis management, increased focus on product affordability, rise in preventative treatments and vaccines, increased use of biologics for allergy treatment.
The forecast of 8.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. emergency medicine by increasing costs for epinephrine auto-injectors and intravenous (IV) antihistamines imported from UK and Switzerland, potentially compromising rapid response capabilities and raising Emergency Room(ER) medication expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of food allergies is expected to drive the growth of the anaphylaxis market in the coming years. Food allergies are immune system reactions triggered by certain foods, causing symptoms that can range from mild to severe, including life-threatening anaphylaxis. The rising prevalence of food allergies can be attributed to factors such as changing dietary habits, environmental influences, and improved awareness and diagnosis. Anaphylaxis treatment plays a crucial role in providing life-saving intervention for food allergy patients, rapidly reversing severe allergic reactions, alleviating symptoms such as swelling, difficulty breathing, and a drop in blood pressure, ensuring immediate stabilization, and preventing potentially fatal outcomes. It also equips patients with tools for timely action in future allergic incidents. For example, in September 2024, the World Health Organization (WHO) reported that around 220 million people worldwide are affected by food allergies. A single food product can contain multiple allergens, and individuals may be allergic to more than one type of food. Additionally, the Food Standards Agency (FSA) released a report in May 2024 revealing that over 30% of adults in the UK experienced food-related adverse reactions, and clinical assessments confirmed food allergies in approximately 6% of UK adults, which equals around 2.4 million people. Thus, the increasing prevalence of food allergies is driving growth in the anaphylaxis market.
Companies in the anaphylaxis market are focused on advancing treatments, including the development of epinephrine nasal sprays that allow for faster and more efficient drug delivery in emergencies. Epinephrine nasal sprays are medical devices that administer epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For example, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced that Neffy (epinephrine nasal spray) received approval from the US Food and Drug Administration (FDA), making it the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while providing rapid, life-saving epinephrine during severe allergic reactions.
In October 2023, Nestle Health Science SA, a Switzerland-based nutritional science company, partnered with Anaphylaxis UK to support individuals with severe allergies. This collaboration is designed to raise awareness about the serious consequences of anaphylaxis and empower individuals to manage allergies safely by providing education and resources. Anaphylaxis UK is a UK-based charity focused on severe allergies.
Major players in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy's Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abello, Stallergenes Greer, Allergy Therapeutics.
North America was the largest region in the anaphylaxis market in 2024. The regions covered in anaphylaxis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the anaphylaxis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The anaphylaxis market consists of syringes and vials, intravenous (IV) epinephrine, diagnostic kits, and monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anaphylaxis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on anaphylaxis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for anaphylaxis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anaphylaxis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Epinephrine; Steroids; Antihistamines; Beta-antagonists; Other Drug Class
2) By Route Of Administration: Parenteral; Oral; Other Routes Of Administration
3) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications
Subsegments:
1) By Epinephrine: Auto-injectors; Prefilled Syringes; Vials
2) By Steroids: Corticosteroids; Glucocorticoids; Mineralocorticoids
3) By Antihistamines: H1-receptor Antagonists; H2-receptor Antagonists
4) By Beta-antagonists: Selective Beta-blockers; Non-selective Beta-blockers
5) By Other Drug Class: Leukotriene Receptor Antagonists; Mast Cell Stabilizers
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG; Sanofi SA; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline Plc; F. Hoffman-La Roche Ltd.; Teva Pharmaceutical Industries Ltd.; Bausch Health Companies Inc.; Perrigo Company plc; Dr Reddy's Laboratories Ltd.; Cipla Ltd.; Amneal Pharmaceuticals Inc.; Mylan N.V.; ALK-Abello; Stallergenes Greer; Allergy Therapeutics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Anaphylaxis Market Characteristics
3. Anaphylaxis Market Trends And Strategies
4. Anaphylaxis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Anaphylaxis Growth Analysis And Strategic Analysis Framework
5.1. Global Anaphylaxis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Anaphylaxis Market Growth Rate Analysis
5.4. Global Anaphylaxis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Anaphylaxis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Anaphylaxis Total Addressable Market (TAM)
6. Anaphylaxis Market Segmentation
6.1. Global Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Epinephrine
Steroids
Antihistamines
Beta-antagonists
Other Drug Class
6.2. Global Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parenteral
Oral
Other Routes Of Administration
6.3. Global Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Food Allergy
Pollen Allergy
Dust Mites Allergy
Other Applications
6.4. Global Anaphylaxis Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Auto-injectors
Prefilled Syringes
Vials
6.5. Global Anaphylaxis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Glucocorticoids
Mineralocorticoids
6.6. Global Anaphylaxis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
H1-receptor Antagonists
H2-receptor Antagonists
6.7. Global Anaphylaxis Market, Sub-Segmentation Of Beta-antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Selective Beta-blockers
Non-selective Beta-blockers
6.8. Global Anaphylaxis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukotriene Receptor Antagonists
Mast Cell Stabilizers
7. Anaphylaxis Market Regional And Country Analysis
7.1. Global Anaphylaxis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Anaphylaxis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Anaphylaxis Market
8.1. Asia-Pacific Anaphylaxis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Anaphylaxis Market
9.1. China Anaphylaxis Market Overview
9.2. China Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Anaphylaxis Market
10.1. India Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Anaphylaxis Market
11.1. Japan Anaphylaxis Market Overview
11.2. Japan Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Anaphylaxis Market
12.1. Australia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Anaphylaxis Market
13.1. Indonesia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Anaphylaxis Market
14.1. South Korea Anaphylaxis Market Overview
14.2. South Korea Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Anaphylaxis Market
15.1. Western Europe Anaphylaxis Market Overview
15.2. Western Europe Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Anaphylaxis Market
16.1. UK Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Anaphylaxis Market
17.1. Germany Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Anaphylaxis Market
18.1. France Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Anaphylaxis Market
19.1. Italy Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Anaphylaxis Market
20.1. Spain Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Anaphylaxis Market
21.1. Eastern Europe Anaphylaxis Market Overview
21.2. Eastern Europe Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Anaphylaxis Market
22.1. Russia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Anaphylaxis Market
23.1. North America Anaphylaxis Market Overview
23.2. North America Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Anaphylaxis Market
24.1. USA Anaphylaxis Market Overview
24.2. USA Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Anaphylaxis Market
25.1. Canada Anaphylaxis Market Overview
25.2. Canada Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Anaphylaxis Market
26.1. South America Anaphylaxis Market Overview
26.2. South America Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Anaphylaxis Market
27.1. Brazil Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Anaphylaxis Market
28.1. Middle East Anaphylaxis Market Overview
28.2. Middle East Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Anaphylaxis Market
29.1. Africa Anaphylaxis Market Overview
29.2. Africa Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Anaphylaxis Market Competitive Landscape And Company Profiles
30.1. Anaphylaxis Market Competitive Landscape
30.2. Anaphylaxis Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Anaphylaxis Market Other Major And Innovative Companies
31.1. Sanofi SA
31.2. AstraZeneca plc
31.3. Abbott Laboratories
31.4. GlaxoSmithKline Plc
31.5. F. Hoffman-La Roche Ltd.
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Bausch Health Companies Inc.
31.8. Perrigo Company plc
31.9. Dr Reddy's Laboratories Ltd.
31.10. Cipla Ltd.
31.11. Amneal Pharmaceuticals Inc.
31.12. Mylan N.V.
31.13. ALK-Abello
31.14. Stallergenes Greer
31.15. Allergy Therapeutics
32. Global Anaphylaxis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Anaphylaxis Market
34. Recent Developments In The Anaphylaxis Market
35. Anaphylaxis Market High Potential Countries, Segments and Strategies
35.1 Anaphylaxis Market In 2029 - Countries Offering Most New Opportunities
35.2 Anaphylaxis Market In 2029 - Segments Offering Most New Opportunities
35.3 Anaphylaxis Market In 2029 - Growth Strategies
